공지 • Jul 09
CBM Bancorp Common Stock Deleted from Other OTC CBM Bancorp, Inc. Common Stock has been deleted from Other OTC effective July 08, 2022. The deletion is due to Acquisition /Merger /Amalgamation. 공지 • Jan 30
Rosedale Federal Savings and Loan Association entered into definitive merger agreement to acquire CBM Bancorp, Inc. (OTCPK:CBMB) for $62.5 million. Rosedale Federal Savings and Loan Association entered into definitive merger agreement to acquire CBM Bancorp, Inc. (OTCPK:CBMB) for $62.5 million on January 28, 2022. Under the terms of agreement, Rosedale Federal is acquiring CBM Bancorp in an all-cash transaction for an aggregate purchase price of $64.4 million and the stockholders of CBM Bancorp will be entitled to receive $17.75 in cash for each share of CBM Bancorp common stock they own. In connection with the execution of the merger agreement, Rosedale has entered into stockholder agreements with the directors and executive officers of CBM Bancorp. Subject to the terms and conditions of the stockholder agreements, these parties have agreed to vote their shares in favor of the transaction. The transaction will expand Rosedale Federal's footprint in Maryland and complement its ongoing strategy of continuous growth to benefit account holders and drive business goals, as well as offer Chesapeake Bank of Maryland's customers a larger banking network and more convenient banking options.
The transaction is subject to the satisfaction of customary closing conditions, including regulatory approvals and the approval of CBM Bancorp's stockholders. The transaction has been approved unanimously by the Boards of Directors of both entities. The merger is expected to be consummated during the first half of 2022. Performance Trust Capital Partners, LLC is serving as financial advisor, and Luse Gorman, PC is serving as legal counsel to Rosedale Federal in this transaction. Piper Sandler & Co. is serving as financial advisor, and Jones Walker LLP, Washington, DC, is serving as legal counsel to CBM Bancorp. Upcoming Dividend • Sep 20
Upcoming dividend of US$0.50 per share Eligible shareholders must have bought the stock before 27 September 2021. Payment date: 08 October 2021. Trailing yield: 3.3%. Lower than top quartile of American dividend payers (3.6%). In line with average of industry peers (3.4%). Reported Earnings • Aug 14
Second quarter 2021 earnings released: EPS US$0.03 (vs US$0.037 in 2Q 2020) The company reported a soft second quarter result with weaker earnings and profit margins, although revenues improved. Second quarter 2021 results: Revenue: US$2.18m (up 6.3% from 2Q 2020). Net income: US$104.3k (down 20% from 2Q 2020). Profit margin: 4.8% (down from 6.4% in 2Q 2020). The decrease in margin was driven by higher expenses. 공지 • May 22
CBM Bancorp, Inc. (NasdaqCM:CBMB) announces an Equity Buyback for $2.5 million worth of its shares. CBM Bancorp, Inc. (NasdaqCM:CBMB) announces a share repurchase program. Under the program, the company will repurchase up to $2.5 million worth of its outstanding shares. The program will be valid through December 31, 2021. Reported Earnings • May 15
First quarter 2021 earnings released: EPS US$0.04 (vs US$0.046 in 1Q 2020) The company reported a soft first quarter result with weaker earnings and profit margins, although revenues improved. First quarter 2021 results: Revenue: US$2.01m (up 2.3% from 1Q 2020). Net income: US$121.7k (down 30% from 1Q 2020). Profit margin: 6.0% (down from 8.8% in 1Q 2020). The decrease in margin was driven by higher expenses. Reported Earnings • Mar 28
Full year 2020 earnings released: EPS US$0.26 (vs US$0.23 in FY 2019) The company reported a solid full year result with improved earnings and revenues, although profit margins were flat. Full year 2020 results: Revenue: US$8.51m (up 5.7% from FY 2019). Net income: US$942.6k (up 3.8% from FY 2019). Profit margin: 11% (in line with FY 2019). Is New 90 Day High Low • Feb 27
New 90-day high: US$14.65 The company is up 11% from its price of US$13.25 on 27 November 2020. The American market is up 2.0% over the last 90 days, indicating the company outperformed over that time. However, its price trend is similar to the Mortgage industry, which is also up 11% over the same period. Is New 90 Day High Low • Jan 07
New 90-day high: US$14.43 The company is up 13% from its price of US$12.75 on 08 October 2020. The American market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Mortgage industry, which is up 5.0% over the same period. Is New 90 Day High Low • Dec 16
New 90-day high: US$14.07 The company is up 16% from its price of US$12.16 on 16 September 2020. The American market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Mortgage industry, which is up 9.0% over the same period. Reported Earnings • Nov 14
Third quarter 2020 earnings released: EPS US$0.07 The company reported a poor third quarter result with weaker earnings and profit margins, although revenues were flat. Third quarter 2020 results: Revenue: US$2.16m (flat on 3Q 2019). Net income: US$250.8k (down 17% from 3Q 2019). Profit margin: 12% (down from 14% in 3Q 2019). The decrease in margin was primarily driven by higher expenses. Is New 90 Day High Low • Nov 10
New 90-day high: US$13.00 The company is up 8.0% from its price of US$12.05 on 12 August 2020. The American market is up 7.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Mortgage industry, which is down 2.0% over the same period. Is New 90 Day High Low • Oct 15
New 90-day high: US$12.91 The company is up 9.0% from its price of US$11.81 on 17 July 2020. The American market is up 11% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Mortgage industry, which is down 1.0% over the same period.